Four PGIMER Doctors have been selected for ICMR Awards

Dr Sanjay Bhadada from Department of Endocrinology has been selected for Smt. Dr. Kunti & Om Prakash Oration award for his seminal work on primary hyper parathyroidism. Dr. Bhadada from last 15 years has been working on various aspects of primary hyper parathyroidism. He also made national online registry of primary hyper parathyroidism ( and rare metabolic bone disease ( registry.

Dr. Amit Rawat is a Professor of Pediatric Allergy and Immunology at the Department of Pediatrics, Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh. He is the recipient of the BGRC Silver Jubilee Oration Award 2018 from Indian Council of Medical Research (ICMR) for his research work on Primary Immunodeficiency Diseases. Primary immunodeficiency diseases also referred to as inborn errors of immunity are a heterogeneous group of genetic defects involving different components of the adaptive and innate immune system.

Dr. Rawat is an investigator in the Department of Health Research and Indian Council of Medical Research sponsored Centre of Advanced Research in Primary Immunodeficiency at the Department of Pediatrics, PGIMER, Chandigarh. He is the first to describe early complement defects in a pediatric cohort of systemic lupus erythematosus (SLE) from India. Children with early complement component deficiencies present with early-onset lupus which has no sex predilection and unique clinical and immunological features. Pathogenic variants in the C1QA gene encoding for the A chain of the C1q protein were also first described in an Indian cohort of pediatric lupus patients.

Dr Rawat has also described the clinical, immunological and genetic basis of chronic granulomatous disease from India. Autosomal recessive form of CGD was found to be more common than X-linked CGD in this study in striking contrast to data from developed western nations where X-linked CGD is more common. Dr. Rawat has documented a unique microbial profile in patients with chronic granulomatous disease from India with the detection of unusual microorganisms such as Fusarium dimerium and Chryseobacterium gleum. Dr Rawat is a founder member and
Secretary of the Indian Society for Primary Immune Deficiency. He has 110 publications to his credit in peer-reviewed national and international journals.

Prof BC Srivastava Foundation Award is being awarded to Dr. Shankar Prinja, Additional Professor of Health Economics at the PGIMER, Department of Community Medicine and School of Public Health, received his masters in health economics at the London School of Hygiene and Tropical Medicine and London School of Economics. His main research interests involve economic evaluation of health care interventions and programs, costing of health care services,and analyzing impact of health financing policies in the context of universal health coverage. He is a member of several high level policy groups including the subgroups of Prime Minister’s Economic Advisory Council on “Investment in Human Resources and Infrastructure” as well as “Converging Health Care and Social Security Financing Platforms”, Government of India’s task force on costing for health care services; Technical Appraisal Committee for Health Technology Assessment Board; and the Research Advisory Council of the Public Health Foundation of India. He has been a Consultant to World Bank, WHO, UNFPA and UNICEF. He has set up the Regional Resource Centre for India’s Health Technology Assessment Board; and the Innovation and Learning Centre for Health and Wellness Centres in Punjab. He is currently leading a national study to determine the payment rates under the Ayushman Bharat Prime Minister’s Jan Arogya Yojana. He has authored 149 research papers in leading national and international peer-reviewed scientific journals. He is also an Academic Editor of the PLoS One and member of the editorial board of Pharmacoeconomics Open.

Dr. P.N Raju Oration Award would be given to Dr. Ravindra Khaiwal, Additional Professor, Community Medicine who has leading research in the area of environmental health at the Department of Community Medicine and School of Public Health, PGI, Chandigarh. The research conducted by Dr. Khaiwal focuses to better understand environmental pollution and exposure to minimize the adverse health impact on the general public. He developed an exposure index for health risk assessment and identified barriers for cleaner alternatives, proposed sustainable model for pollution mitigation and climate change adaption. He also developed the methodology for exhaust and non-exhaust source profile and conducted air pollution trend analysis for evidence-based policy intervention and provided support for science policy framework. He is actively engaged in developing low-cost sustainable solutions for air, and water pollution to promote better health and environment.

Dr. Khaiwal has received several awards and scholarships in the field of ‘Environmental Health’ and was the finalist of ‘Elsevier NASI-SCOPUS 2014’ Young Scientist Award. Recently, he was also awarded the US Department of State ‘International Visitors Leadership Fellowship (IVLP-2018).


“World Chronic Myeloid Leukemia (CML) Day”- PGI to hold public awareness program
Chronic Myeloid Leukemia (CML) is a type of blood cancer that is now considered curable in majority of patients who present in early stage. The cure of this cancer is possible with the help of medicine called as “Magic Bullet” or Imatinibmesylate. The average life of patient with this type of cancer was only 2-3 years before the advent of this medicine. This cancer is now considered as chronic disease like diabetes and hypertension. Since 2001, PGI, Chandigarh in association with The Max Foundation is providing this medicine free of cost to patients who are not able to afford. The number of patients living with this type of cancer and are in good state of health have increased tremendously signifying the magic of this medicine. The patient taking the medicine regularly and with regular health checkup can expect a normal life expectancy.

To create public awareness about cure of this cancer, 22nd September is celebrated as “World CML Day”. Following the motto "all united, all unique", World CML Day reminds us that a close collaboration between scientists, clinicians and patient organisations is key to improving the outcomes for patients with CML around the world.

More than 3000 patients of this cancer come to PGI Chandigarh and almost half of them get medicines free of cost with the help of The Max Foundation.

The Departments of Internal Medicine and Hematology with the help of Friends of Max and The Max Foundation celebrate CML day with CML patients once in every two years. This time the meeting is being held on 22nd September 2019 at Bhargava Auditorium from 9 AM to 1 PM. More than 1000 patients and their family members are likely to attend this meeting.